The mRNA Cancer Vaccines and Therapeutics Market is rapidly evolving, with significant shifts in market share expected in the coming years. Currently valued at approximately USD 6.25 billion in 2024, the market is projected to expand to USD 39.01 billion by 2035, reflecting robust growth potential. The ongoing evolution of mRNA technology is creating new opportunities for market entrants, while...